Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy

Yasoo Sugiura,1 Etsuo Nemoto,1 Osamu Kawai,2 Yasuyuki Ohkubo,2 Hisae Fusegawa,2 Shizuka Kaseda1 1Department of Pulmonary and Thoracic Surgery, 2Department of Respiratory Medicine, Kanagawa National Hospital, Hadano, Japan Background: Gefitinib is known as one of the agents for treating patients with...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sugiura Y, Nemoto E, Kawai O, Ohkubo Y, Fusegawa H, Kaseda S
Format: article
Langue:EN
Publié: Dove Medical Press 2013
Sujets:
Accès en ligne:https://doaj.org/article/78374b2549a942babf80989947c6b5ba
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!